Detection and separation of mitoxantrone and its metabolites in plasma and urine by high-performance liquid chromatography
- 31 December 1984
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 342 (1) , 119-127
- https://doi.org/10.1016/s0378-4347(00)84494-1
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Mitoxantrone metabolism in the isolated perfused rat liverCancer Chemotherapy and Pharmacology, 1984
- Disposition of mitoxantrone in patientsCancer Treatment Reviews, 1983
- Therapeutic activity of mitoxantrone and ametantrone against murine tumorsCancer Treatment Reviews, 1983
- Mitoxantrone hydrochloride (NSC-310739) in lymphomaInvestigational New Drugs, 1983
- Improved high-performance liquid chromatography of the new antineoplastic agents bisantrene and mitoxantroneJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Clinical kinetics of 1,4-dihydroxy-5,8-bis [[2- [(2-hydroxyethyl)amino ]ethyl] amino]-9,10-anthracenedioneClinical Pharmacology & Therapeutics, 1982
- Clinical analysis for the anti-neoplastic agent 1,4-dihydroxy-5,8-bis{{2-[(2-hydroxyethyl)amino]ethyl}amino} 9,10-anthracenedione dihydrochloride (NSC 301739) in plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- An HPLC Method for the Quantitative Determination of 1,4-Dihydroxy-5,8 Bis [[2-[(2-Hydroxyethyl) Amino] Ethyl] Amino] 9,10 - Anthracenedione (DHAQ, Lederle Labs CL232 315, NCS 301739) in SerumJournal of Liquid Chromatography, 1980
- EXPERIMENTAL ANTI-TUMOR ACTIVITY OF AMINOANTHRAQUINONES1979